Melanotropic peptides increase permeability of plasma/cerebrospinal fluid barrier.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology* / Q000502:physiology; D000418:Albumins / Q000378:metabolism; D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D002831:Choroid Plexus / Q000378:metabolism*; D002946:Cisterna Magna; D004305:Dose-Response Relationship, Drug; D007267:Injections; D007444:Inulin / Q000378:metabolism; D008297:Male; D008353:Mannitol / Q000378:metabolism; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology* / Q000502:physiology; D010455:Peptides / Q000494:pharmacology* / Q000502:physiology; D011817:Rabbits; D013395:Sucrose / Q000378:metabolism; D013997:Time Factors
D000418:Albumins; D010455:Peptides; D008353:Mannitol; D013395:Sucrose; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D007444:Inulin